celecoxib has been researched along with Gastritis, Atrophic in 1 studies
Gastritis, Atrophic: GASTRITIS with atrophy of the GASTRIC MUCOSA, the GASTRIC PARIETAL CELLS, and the mucosal glands leading to ACHLORHYDRIA. Atrophic gastritis usually progresses from chronic gastritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheu, BS | 1 |
| Tsai, YC | 1 |
| Wu, CT | 1 |
| Chang, WL | 1 |
| Cheng, HC | 1 |
| Yang, HB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis.[NCT05544396] | 100 participants (Anticipated) | Interventional | 2023-11-08 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for celecoxib and Gastritis, Atrophic
| Article | Year |
|---|---|
Long-term celecoxib can prevent the progression of persistent gastric intestinal metaplasia After H. pylori eradication.
Topics: Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Gastritis, Atrophic; Helicobacter Infections; | 2013 |